Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 38.82%6.22B | 46.86%2.82B | 3.05%4.48B | 1.16%1.92B | 33.57%4.35B | 34.67%1.9B | -23.52%3.25B | -42.14%1.41B | 40.26%4.26B | 106.18%2.43B |
| Operating income | 38.82%6.22B | 46.86%2.82B | 3.05%4.48B | 1.16%1.92B | 33.57%4.35B | 34.67%1.9B | -23.52%3.25B | -42.14%1.41B | 40.26%4.26B | 106.18%2.43B |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Depreciation and amortization | -11.66%-1.12B | -2.82%-481.1M | -8.12%-1.01B | -4.93%-467.9M | -17.73%-930.2M | -27.00%-445.9M | 12.02%-790.1M | 22.68%-351.1M | 3.21%-898M | -11.60%-454.1M |
| Impairment and provision | -447.17%-290M | ---- | ---53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -447.17%-290M | ---- | ---53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | -15.45%-2.81B | -12.10%-1.28B | 15.74%-2.43B | 9.62%-1.14B | -67.83%-2.88B | -66.65%-1.26B | -12.37%-1.72B | 19.09%-756.3M | 7.52%-1.53B | -17.33%-934.8M |
| Operating profit | 101.93%2B | 240.34%1.06B | 86.20%990M | 63.82%311.1M | -28.66%531.7M | -36.83%189.9M | -59.22%745.3M | -71.22%300.6M | 304.38%1.83B | 4,583.26%1.04B |
| Financing income | -21.62%17.4M | -49.26%6.9M | -8.64%22.2M | 216.28%13.6M | 62.00%24.3M | 26.47%4.3M | 177.78%15M | 325.00%3.4M | 184.21%5.4M | -33.33%800K |
| Financing cost | 25.92%-289.5M | 19.38%-146.4M | -6.66%-390.8M | 1.63%-181.6M | -22.21%-366.4M | -31.39%-184.6M | 8.88%-299.8M | 17.35%-140.5M | 18.04%-329M | 23.29%-170M |
| Earning before tax | 177.92%1.73B | 542.42%919.3M | 227.74%621.4M | 1,390.63%143.1M | -58.83%189.6M | -94.13%9.6M | -69.38%460.5M | -81.32%163.5M | 2,769.85%1.5B | 459.21%875.4M |
| Tax | -202.19%-771.8M | -455.03%-353M | -278.37%-255.4M | -84.35%-63.6M | 68.89%-67.5M | 53.19%-34.5M | 62.80%-217M | 74.71%-73.7M | -1,146.37%-583.3M | -577.70%-291.4M |
| After-tax profit from continuing operations | 160.98%955.2M | 612.33%566.3M | 199.75%366M | 419.28%79.5M | -49.86%122.1M | -127.73%-24.9M | -73.55%243.5M | -84.62%89.8M | 16,337.50%920.5M | 419.65%584M |
| Earning after tax | 160.98%955.2M | 612.33%566.3M | 199.75%366M | 419.28%79.5M | -49.86%122.1M | -127.73%-24.9M | -73.55%243.5M | -84.62%89.8M | 16,337.50%920.5M | 419.65%584M |
| Minority profit | 118.42%445.8M | 287.50%226.3M | 80.46%204.1M | 72.27%58.4M | 59.07%113.1M | 229.13%33.9M | -71.94%71.1M | -94.40%10.3M | 260.46%253.4M | 844.53%183.9M |
| Profit attributable to shareholders | 214.64%509.4M | 1,511.37%340M | 1,698.89%161.9M | 135.88%21.1M | -94.78%9M | -173.96%-58.8M | -74.16%172.4M | -80.13%79.5M | 1,131.07%667.1M | 353.23%400.1M |
| Basic earnings per share | 174.51%0.042 | 1,117.39%0.028 | 1,430.00%0.0153 | 135.94%0.0023 | -95.00%0.001 | -169.57%-0.0064 | -74.84%0.02 | -81.26%0.0092 | 1,093.75%0.0795 | 350.51%0.0491 |
| Diluted earnings per share | 175.66%0.0419 | 1,117.39%0.028 | 1,420.00%0.0152 | 135.94%0.0023 | -94.95%0.001 | -169.57%-0.0064 | -74.81%0.0198 | -81.07%0.0092 | 1,082.50%0.0786 | 347.96%0.0486 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.